Research programme: nonsteroidal glucocorticoid receptor agonists - Boehringer Ingelheim
Latest Information Update: 04 Nov 2017
At a glance
- Originator Boehringer Ingelheim
- Class Aza compounds; Indoles; Small molecules
- Mechanism of Action Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation; Rheumatoid arthritis
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Inflammation in USA (PO)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Rheumatoid-arthritis in USA (PO)